How many clinical trials are tracked of palonosetron?

25 trials are tracked, 4 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

palonosetron

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of palonosetron

25 trials tracked of palonosetron: 12 in phase 3 or 4 and 4 with published results. The most-cited published study has 251 citations.

25Trials tracked

12Phase 3 & 4

0Recruiting

4With published results

Phase distribution

Phase 3 12 Phase 2 8 Other / NA 5

Phase 3 Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting Completed · 251 cited
Phase 3 APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer Completed · 14 cited
Phase 3 Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer Completed · 6 cited
Phase 3 Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy Completed · 2 cited
Phase 3 An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting Completed
Phase 3 Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer Completed

Show 19 more trials

Phase 3 Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients Completed
Phase 3 Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial Completed
Phase 3 Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients Completed
Phase 3 A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting Completed
Phase 3 An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting Completed
Phase 3 Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients Completed
Phase 2 Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients Completed
Phase 2 Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU) Completed
Phase 2 Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant Completed
Phase 2 PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting Completed
Phase 2 Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting Completed
Phase 2 Multi-day Doses in Prevention of Nausea and Emesis Completed
Phase 2 Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting Completed
Phase 2 Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX Completed
N/A Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant Completed
N/A Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal Completed
N/A Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) Completed
N/A Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis Completed
N/A Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.